PGx Comprehensive is a complete pharmacogenomics clinical support tool to assist guidance for various medication decions. It's aims is to lessen the trial and error of prescribing by providing evidence-based, professionally guided medication alerts that are based on your patient’s genetics. The test analyses fifteen genes, covering liver metabolism, as well as drug transporters and receptors. The report can help select the most appropriate medication for your patient, particularly if they are suffering from a chronic pain, mental illness or conditions associated with blood pressure, clotting, or following a stent procedure. It has been found to be particularly useful for patients taking multiple medications, or those who have had medication failures or experienced significant side-effects. It can also be useful even before commencing medication, enabling the right medication selection for your patient, the first time.
Drug Classes Reported:
- Antiplatelet Agents
- Beta Blockers
- Protein Pump Inhibitors
The report provides evidence-based, genetically guided medication alerts and recommendations from preeminent, expert international bodies, including the US Food and Drug Administration, the Clinical Pharmacogenomics Implementation Consortium, and the Dutch Pharmacogenomics Working Group.
Note: The information contained in the report is intended to be interpreted by a treating clinician. The report is not intended to take the place of professional medical advice. Decisions on the use of medications must be made only after consulting with the treating clinician and should consider the patient's medical history and current treatment regimen.